These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3903519

  • 1. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man.
    Heavey DJ, Barrow SE, Hickling NE, Ritter JM.
    Nature; ; 318(6042):186-8. PubMed ID: 3903519
    [Abstract] [Full Text] [Related]

  • 2. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM, Pulvermacher G, Mayo G, Fitzgerald DJ.
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [Abstract] [Full Text] [Related]

  • 3. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ, Mayo G, Price P, FitzGerald GA.
    N Engl J Med; 1991 Oct 17; 325(16):1137-41. PubMed ID: 1891022
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
    Kyrle PA, Eichler HG, Jäger U, Lechner K.
    Circulation; 1987 May 17; 75(5):1025-9. PubMed ID: 3552295
    [Abstract] [Full Text] [Related]

  • 5. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
    Ritter JM.
    Br J Pharmacol; 1984 Oct 17; 83(2):409-18. PubMed ID: 6386089
    [Abstract] [Full Text] [Related]

  • 6. Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Analysis of the effects of a combination of aspirin and n-3 fatty acids on the eicosanoid profile.
    Force T, Milani R, Hibberd P, Lorenz R, Uedelhoven W, Leaf A, Weber P.
    Circulation; 1991 Dec 17; 84(6):2286-93. PubMed ID: 1959184
    [Abstract] [Full Text] [Related]

  • 7. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA, Minar E, Brenner B, Eichler HG, Heistinger M, Marosi L, Lechner K.
    Thromb Haemost; 1989 Jun 30; 61(3):374-7. PubMed ID: 2508252
    [Abstract] [Full Text] [Related]

  • 8. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF, Wright KF, Jones PS, Richardson DW, Ellis CK.
    J Cardiovasc Pharmacol; 1980 Jun 30; 2(4):387-97. PubMed ID: 6156337
    [Abstract] [Full Text] [Related]

  • 9. Effect of single-dose aspirin on TXA2 and PGI2 cyclooxygenases in vivo.
    Zaragoza R, Le Breton GC.
    Haemostasis; 1987 Jun 30; 17(1-2):40-8. PubMed ID: 3110025
    [Abstract] [Full Text] [Related]

  • 10. Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxane synthesis in vitro.
    Toivanen JL.
    Prostaglandins Leukot Med; 1987 Mar 30; 26(3):265-80. PubMed ID: 3554268
    [Abstract] [Full Text] [Related]

  • 11. Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells.
    Martin W, Drazan KM, Newby AC.
    Br J Pharmacol; 1989 May 30; 97(1):51-6. PubMed ID: 2541859
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of thromboxane A2 and prostacyclin synthesis by low dose acetylsalicylic acid in atherosclerotic patients.
    Carlsson I, Benthin G, Petersson AS, Wennmalm A.
    Thromb Res; 1990 Feb 01; 57(3):437-44. PubMed ID: 2107595
    [Abstract] [Full Text] [Related]

  • 13. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
    Schafer AI, Crawford DD, Gimbrone MA.
    J Clin Invest; 1984 Apr 01; 73(4):1105-12. PubMed ID: 6423665
    [Abstract] [Full Text] [Related]

  • 14. Recovery of prostacyclin synthesis by rabbit aortic endothelium and other tissues after inhibition by aspirin.
    Frazer CE, Ritter JM.
    Br J Pharmacol; 1987 May 01; 91(1):251-6. PubMed ID: 3297227
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ.
    N Engl J Med; 1981 Jan 08; 304(2):76-9. PubMed ID: 7003384
    [Abstract] [Full Text] [Related]

  • 16. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA, Oates JA.
    Clin Pharmacol Ther; 1984 May 08; 35(5):633-40. PubMed ID: 6370554
    [Abstract] [Full Text] [Related]

  • 17. In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia.
    Cavalca V, Rocca B, Squellerio I, Dragani A, Veglia F, Pagliaccia F, Porro B, Barbieri SS, Tremoli E, Patrono C.
    Thromb Haemost; 2014 Jul 03; 112(1):118-27. PubMed ID: 24671522
    [Abstract] [Full Text] [Related]

  • 18. Measurements of the in vivo synthesis of thromboxane and prostacyclin in humans.
    Vesterqvist O.
    Scand J Clin Lab Invest; 1988 Sep 03; 48(5):401-7. PubMed ID: 3060985
    [Abstract] [Full Text] [Related]

  • 19. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.
    McIntyre TM, Zimmerman GA, Satoh K, Prescott SM.
    J Clin Invest; 1985 Jul 03; 76(1):271-80. PubMed ID: 2862164
    [Abstract] [Full Text] [Related]

  • 20. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J, Mehta P, Lawson DL, Ostrowski N, Brigmon L.
    J Lab Clin Med; 1985 Sep 03; 106(3):246-52. PubMed ID: 3928780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.